CXCL8 and colorectal carcinoma: Pooled analysis of the eight studies (1710 patients) reporting PFS data revealed a significantly higher risk of progression or death for CRC patients with high versus low IL-8 expression (pooled HR by random effect model: 1.639; 95% CI: 1.199–2.239; p = 0.002) (Figure 4A).